The overarching objective of this project is to establish a tissue bank comprised of CNS autopsy material from HIV-infected individuals who are well-characterized neuropsychologically and neuromedically within six months of death. The CNTN represents a collaboration of investigators from the NIMH-funded HIV Neurobehavioral Research Center (HNRC) in San Diego and from four California HIV network sites: University of Southern California/LA County, Cedars-Sinai/University of California, Los Angeles, University of California, Irvine, and the University of California, San Diego. Collectively, these sites follow over 4,300 AIDS patients.
The specific aims of the CNTN are: 1) to identify a group of HIV plus persons with advanced disease who agree to be evaluated and consent to autopsy; 2) to characterize these individuals neuromedically and neurobehaviorally using a standardized protocol; 3) to assure that antemortem data are available within 6 months of death; 4) to perform autopsies within 24 hours of death; 5) to characterize the neuropathologic changes associated with HIV; 6) to establish a tissue registry and repository; 7) to establish a database that can support current and future investigator initiated studies integrating antemortem and postmortem data; 8) to establish a process whereby investigators can access tissue and data; and 9) to obtain control tissues. The CNTN consists of a structure and processes for identifying, characterizing and maintaining a cohort of 250 persons with advanced HIV disease in anticipation of their death, of harvesting CNS and other tissues promptly (n=50 annually), of describing, cataloging, and storing these at a central facility in San Diego, and making such materials and data available to investigators to perform scholarly work on neuroAIDS. At the end of 5 years, the CNTN proposes to acquire 209 sets of brain and other tissues from HIV plus individuals for whom there is detailed antemortem characterization. Fifty more brains are expected to be accumulated from other individuals dying with HIV disease, who have interesting neuropathology (e.g., PML), but for whom antemortem information is more limited. We will also accumulate 75 control brains from immunosuppressed patients dying after transplantation or from trauma. The CNTN sites will be coordinated by a core facility in San Diego including a Neuropathology and Banking Unit, a Protocol Monitoring Unit, and a Data Coordinating Unit. An Administrative Unit oversees the operations of the core and network sites, assisted by an internal multi- investigator committee as well as an external Scientific Advisory Board. The significance of the CNTN arises from the demographically and neuropathologically broad representation of cases that will be entered into the network from multiple sites in Southern California. The feasibility of the CNTN is supported by the experience of investigators in implementing standardized protocols of antemortem and postmortem evaluation, as well as the record of this team in successful multidisciplinary and multisite longitudinal investigations.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Resource-Related Research Projects (R24)
Project #
5R24MH059745-02
Application #
2891172
Study Section
Special Emphasis Panel (ZRG5-AARR-7 (03))
Program Officer
Rausch, Dianne M
Project Start
1998-09-30
Project End
2003-05-31
Budget Start
1999-06-01
Budget End
2000-05-31
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Psychiatry
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Marquine, María J; Flores, Ilse; Kamat, Rujvi et al. (2018) A composite of multisystem injury and neurocognitive impairment in HIV infection: association with everyday functioning. J Neurovirol 24:549-556
Mukerji, Shibani S; Misra, Vikas; Lorenz, David R et al. (2018) Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1-Infected Adults in the United States. Clin Infect Dis 67:1182-1190
Vestberg, Susanna; Nordström, Erik Blennow; Waldö, Maria Landqvist et al. (2018) Swedish Version of the Hayling Test: Clinical Utility in Frontotemporal Dementia Syndromes. J Int Neuropsychol Soc :1-9
Oppenheim, Hannah; Paolillo, Emily W; Moore, Raeanne C et al. (2018) Neurocognitive functioning predicts frailty index in HIV. Neurology 91:e162-e170
Paolillo, Emily W; Gongvatana, Assawin; Umlauf, Anya et al. (2017) At-Risk Alcohol Use is Associated with Antiretroviral Treatment Nonadherence Among Adults Living with HIV/AIDS. Alcohol Clin Exp Res 41:1518-1525
Vitomirov, Andrej; Ramirez-Gaona, Miguel; Mehta, Sanjay R et al. (2017) Random shearing as an alternative to digestion for mitochondrial DNA processing in droplet digital PCR. Mitochondrion 32:16-18
Fields, Jerel A; Metcalf, Jeff; Overk, Cassia et al. (2017) The anticancer drug sunitinib promotes autophagyand protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration. J Neurovirol 23:290-303
Bryant, Alex K; Moore, David J; Burdo, Tricia H et al. (2017) Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection. AIDS 31:973-979
Fazeli, P L; Casaletto, K B; Paolillo, E et al. (2017) Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning. J Clin Exp Neuropsychol 39:842-853
Marquine, María J; Montoya, Jessica L; Umlauf, Anya et al. (2016) The Veterans Aging Cohort Study (VACS) Index and Neurocognitive Change: A Longitudinal Study. Clin Infect Dis 63:694-702

Showing the most recent 10 out of 127 publications